fluorodeoxyglucose f18 has been researched along with Heart Failure in 76 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (14.47) | 18.2507 |
2000's | 15 (19.74) | 29.6817 |
2010's | 35 (46.05) | 24.3611 |
2020's | 15 (19.74) | 2.80 |
Authors | Studies |
---|---|
Haidar, A; Taegtmeyer, H | 1 |
Aguilar-Gallardo, JS; Arreaza, J; Contreras, JP; Lasam, G; Omar, A | 1 |
Lan, X; Qin, C; Song, W; Zhang, X | 1 |
Bartley, P; Bhat, P; Gordon, S; Higgins, A; Jaber, W; Kaur, S | 1 |
Al-Mallah, MH; Chamsi-Pasha, M; Khalaf, S | 1 |
Benz, DC; Buechel, RR; Fuchs, TA; Gaemperli, O; Giannopoulos, AA; Gräni, C; Grossmann, M; Kaufmann, PA; Markendorf, S; Messerli, M; Patriki, D; Pazhenkottil, AP | 1 |
Chiu, KM; Hsu, JC; Huang, SH; Lee, CL; Lin, HH; Shiau, YC; Tsai, HY; Tsai, SY; Tu, CM; Wang, SY; Wu, YW | 1 |
Gliozzi, G; Loforte, A; Martin Suarez, S; Pacini, D | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Ahmed, S; Chen, ES; Constantinescu, F; Devraj, M; Garcia, C; Gilotra, NA; Griffin, JM; Kasper, EK; Mohammed, SF; Okada, DR; Pavlovic, N; Pillarisetty, A; Saad, E; Sheikh, FH; Solnes, L; Wand, AL | 1 |
Wang, Q | 1 |
Zhang, X | 1 |
Avery, R; Cao, J; Cooper, LT; Lomasney, JW; Narang, A; Okwuosa, IS; Passman, RS; Schwartz, YY; Vorovich, E | 1 |
Huang, Z; Liu, Y; Tao, Y; Wang, F | 1 |
Abdelshafee, M; Abouezzeddine, OF; Amin, S; Bois, JP; Chareonthaitawee, P; Christopoulos, G; Cooper, JLT; Elwazir, M; Jouni, H; Kendi, AT; Krause, ML | 1 |
Abdurrachim, D; Bovenkamp, P; Ciapaite, J; Coumans, W; Faber, C; Geraets, IME; Glatz, JFC; Hermann, S; Hoerr, V; Kuhlmann, MT; Luiken, JJFP; Nabben, M; Nicolay, K; Prompers, JJ; Schäfers, M | 1 |
Beitzke, D; Beyer, T; Cal-Gonzalez, J; Hacker, M; Lassen, ML; Rasul, S; Stelzmüller, ME | 1 |
Dou, KF; Fang, W; Feng, L; He, ZX; Lu, MJ; Wang, J; Wang, L; Yang, MF; Zhao, SH | 1 |
Colafranceschi, AS; Dos Santos Miranda, JS; Felix, RCM; Gouvea, CM; Mesquita, CT; Reis, CCW; Schtruk, LBCE | 1 |
Bengel, FM; Ross, TL | 1 |
Kramer, CM; Löffler, AI | 1 |
Absi, M; Adachi, I; Bocchini, C; Price, JF | 1 |
De Rosa, S; Indolfi, C; Iwanaga, Y; Kawamura, T; Miyazaki, S; Nakamura, T; Yasuda, M | 1 |
Blankstein, R; Bravo, PE; Di Carli, MF; Singh, A | 1 |
Delbeke, D; Kiernan, MS | 1 |
Arai-Okuda, H; Mitamura, K; Nishiyama, Y; Norikane, T; Takami, Y; Tani, R; Yamamoto, Y | 1 |
Mehra, MR; Woolley, AE | 1 |
Boutley, H; Karcher, G; Lacolley, P; Lhuillier, M; Louis, H; Marie, PY; Maskali, F; Poussier, S; Thornton, SN | 1 |
Beanlands, RS; Birnie, D; deKemp, RA; Lalonde, M; Ruddy, TD; Wassenaar, R; Wells, RG | 1 |
Fang, W; Guo, F; He, ZX; Li, Y; Wang, DY; Wang, L; Yang, MF; Zhao, SH | 1 |
Beanlands, RS; Birnie, DH; Davis, D; Gollob, MH; Green, M; Healey, JS; Leung, E; McArdle, BA; Nair, GM; Nery, PB; Ohira, H; Yang, J | 1 |
Chen, W; Dilsizian, V; Feller, ED; Kim, J | 1 |
Ahmadi, A; Mielniczuk, LM; Ohira, H | 1 |
Bos, WJ; Grutters, JC; van Moorsel, CH; van Velzen-Blad, H; Verwoerd, A; Vorselaars, AD | 1 |
Fujino, T; Higo, T; Ide, T; Tanoue, Y | 1 |
Alles, S; Dell'Aquila, AM; Deschka, H; Henryk, W; Mastrobuoni, S; Scherer, M; Schneider, SR; Sindermann, JR; Wenning, C | 1 |
Chen, W; Dickfeld, T; Dilsizian, V; Duell, J; Smith, M | 1 |
Barbour, AM; Davila-Roman, VG; Demopoulos, L; Fang, Z; Fossler, M; Gropler, RJ; Haws, T; Lepore, JJ; Olson, E; Russell, SD | 1 |
Higo, T; Ikeda, S; Ohtani, K; Uwatoku, T | 1 |
Abgral, R; Contreras, J; Dweck, MR; Fayad, ZA; Fuster, V; Karakatsanis, N; Kovacic, JC; Lala, A; Mani, V; Miller, M; Narula, J; Padilla, M; Robson, PM; Sanz, J; Trivieri, MG | 1 |
Bouchelouche, K; Bøtker, HE; Flyvbjerg, A; Harms, HJ; Iversen, P; Jorsal, A; Nielsen, R; Sørensen, J; Tolbod, L; Wiggers, H | 1 |
Bouchelouche, K; Gejl, M; Gormsen, LC; Hansen, AK; Tolbod, LP | 1 |
Aktas, MK; Allen, D; Chuang, HH; Jaber, WA; Taylor, DO; Yamani, MH | 1 |
Dunselman, PH; Slart, RH; Tio, RA; van den Heuvel, AF; van der Harst, P; van Veldhuisen, DJ; Voors, AA; Willemsen, AT | 1 |
Abraham, A; Beanlands, RS; Chow, B; DaSilva, J; Davies, RA; deKemp, RA; Duchesne, L; Garrard, L; Guo, A; Haddad, H; Nichol, G; Williams, KA | 1 |
Aung, M; Beanlands, RS; Birnie, D; Burwash, I; DaSilva, JN; Davies, RA; deKemp, RA; Guo, A; Haddad, H; Mielniczuk, LM; Tang, AT; Ukkonen, H; Williams, K; Ziadi, MC | 1 |
Beanlands, RS; Chow, BJ; OMeara, E; Paterson, DI; Ukkonen, H | 1 |
Calafiore, P; Lu, KJ; Rathi, V; Smith, G; Srivastava, PM | 1 |
Bench, T; Brown, DL; Franceschi, D; Matthews, R; Meng, H; Relan, N | 1 |
Castro, P; Chiong, M; Concepción, R; Enríquez, A; García, L; Greig, D; Lavandero, S; Orellana, P; Quintana, JC; Rossel, V; Sepúlveda, L; Sepúlveda, P; Verdejo, H; Winter, JL | 1 |
Drage, MG; Haddad, RI; Lichtman, AH; Shah, SM | 1 |
Graf, S; Porenta, G | 1 |
Inoue, T; Ishikawa, T; Kimura, K; Kobayashi, T; Matsushita, K; Ohkusu, Y; Sumita, S; Takahashi, N; Uchino, K; Umemura, S; Yamakawa, Y | 1 |
Borges-Neto, S; Bourque, JM; O'Connor, CM; Shaw, LK; Velazquez, EJ; Whellan, DJ | 1 |
Camici, PG; Rimoldi, OE | 1 |
Hardoff, R; Maisey, MN; Steinmetz, AP | 1 |
Fukuchi, K; Goto, Y; Hayashida, K; Ishida, Y; Noguchi, T; Sasaki, H; Yokoya, T | 1 |
Iskandrian, AE; Mehta, D | 1 |
Depuey, EG; Ghesani, M; Rozanski, A | 1 |
Iwado, Y; Iwasaki, K; Kono, M; Sakakibara, N; Senda, S; Yukiiri, K | 1 |
Beanlands, DS; Beanlands, RS; Bénard, F; Burwash, IG; DeKemp, RA; Dennie, C; Haddad, H; Mielniczuk, L; Yoshinaga, K | 1 |
Camici, PG; John, AS; Leccisotti, L; Mongillo, M; Pennell, DJ | 1 |
Jain, D; Zaret, BL | 1 |
Brunken, RC; Hawkins, RA; Mody, FV; Nienaber, CA; Phelps, ME; Schelbert, HR | 1 |
Schneider-Eicke, J; Schröter, G; Schwaiger, M | 1 |
Baer, FM; Schicha, H; Schneider, CA; Sechtem, U; Theissen, P; Voth, E; Wagner, R; Wienhard, K | 1 |
Babich, JW; Callahan, RJ; Elmaleh, DR; Fischman, AJ; Strauss, HW; Wakasugi, S; Wilkinson, R | 1 |
Asgarzadie, F; Brunken, RC; Di Carli, MF; Laks, H; Maddahi, J; Phelps, ME; Schelbert, HR | 1 |
Calhoun, WB; Drane, WE; Mills, RM | 1 |
Altehoefer, C; Büchin, P; Büll, U; Hanrath, P; Koch, KC; Messmer, BJ; Schöndube, F; Schulz, G; Schwarz, ER; Sheehan, FH; Uebis, R; vom Dahl, J | 1 |
Bonser, RS; Camici, PG; Horton, R; Littler, WA; Pagano, D; Townend, JN | 1 |
Blanksma, PK; Crijns, HJ; van den Heuvel, AF; van Veldhuisen, DJ | 1 |
Lauer, MS; Lytle, BW; Marwick, TH; Secknus, MA; Williams, J; Zuchowski, C | 1 |
Bonser, RS; Camici, PG; Pagano, D; Parums, DV; Townend, JN | 1 |
Inoue, T; Ishikawa, T; Kimura, K; Kobayashi, T; Matsubara, S; Matsushita, K; Oka, T; Okusu, Y; Sumita, S; Takahashi, N; Uchino, K; Umemura, S; Yamakawa, Y | 1 |
Bax, JJ; Blanksma, PK; Crijns, HJ; Vaalburg, W; van den Heuvel, AF; van Veldhuisen, DJ | 1 |
16 review(s) available for fluorodeoxyglucose f18 and Heart Failure
Article | Year |
---|---|
Strategies for Imaging Metabolic Remodeling of the Heart in Obesity and Heart Failure.
Topics: Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Myocardium; Obesity | 2022 |
Assessment of myocardial viability by PET.
Topics: Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Magnetic Resonance Imaging; Myocardial Ischemia; Myocardial Revascularization; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Survival | 2019 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Emerging imaging targets for infiltrative cardiomyopathy: Inflammation and fibrosis.
Topics: Cardiology; Cardiomyopathies; Disease Progression; Fibrosis; Fluorodeoxyglucose F18; Heart Failure; Humans; Inflammation; Myocardium; Regeneration | 2019 |
Myocardial Viability Testing to Guide Coronary Revascularization.
Topics: Chronic Disease; Coronary Occlusion; Echocardiography, Stress; Fluorodeoxyglucose F18; Heart Failure; Humans; Magnetic Resonance Angiography; Myocardial Revascularization; Myocardial Stunning; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2018 |
Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis.
Topics: Algorithms; Cardiology; Cardiomyopathies; Disease Progression; Fluorodeoxyglucose F18; Heart Failure; Humans; Immunosuppressive Agents; Inflammation; Nuclear Medicine; Positron-Emission Tomography; Prognosis; Sarcoidosis | 2019 |
FDG PET imaging for identifying pulmonary hypertension and right heart failure.
Topics: Fluorodeoxyglucose F18; Glycolysis; Heart Failure; Humans; Hypertension, Pulmonary; Ischemia; Patient Outcome Assessment; Positron-Emission Tomography; Radiopharmaceuticals; Ventricular Dysfunction, Right | 2015 |
Nuclear Imaging Guidance for Ablation of Ventricular Arrhythmias.
Topics: Catheter Ablation; Fluorodeoxyglucose F18; Guanidines; Heart Failure; Humans; Iodine Radioisotopes; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiopharmaceuticals; Tachycardia, Ventricular; Tomography, Emission-Computed, Single-Photon | 2016 |
Recent advances in cardiac imaging for patients with heart failure.
Topics: Echocardiography; Fluorodeoxyglucose F18; Gadolinium; Heart Failure; Humans; Magnetic Resonance Imaging, Cine; Myocardial Perfusion Imaging; Positron-Emission Tomography; Prognosis; Stroke Volume; Systole; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ventricular Function, Left | 2011 |
Radionuclide viability testing: should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease?
Topics: Coronary Disease; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Myocardial Revascularization; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2003 |
Pathophysiology and diagnosis of hibernating myocardium in patients with post-ischemic heart failure: the contribution of PET.
Topics: Blood Flow Velocity; Coronary Circulation; Coronary Vessels; Fluorodeoxyglucose F18; Glucose; Heart; Heart Failure; Humans; Myocardial Ischemia; Myocardial Stunning; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Myocardial viability: nuclear assessment.
Topics: Fluorodeoxyglucose F18; Heart Failure; Humans; Myocardial Ischemia; Myocardial Revascularization; Radiopharmaceuticals; Technetium; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2005 |
Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.
Topics: Echocardiography, Stress; Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Technetium; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2005 |
[Myocardial scintigraphy and PET for diagnosis of heart failure].
Topics: Coronary Circulation; Diagnosis, Differential; Fatty Acids; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Myocardium; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Severity of Illness Index; Sympathetic Nervous System; Tissue Survival; Tomography, Emission-Computed, Single-Photon | 2005 |
Nuclear imaging techniques for the assessment of myocardial viability.
Topics: Acetates; Carbon Radioisotopes; Coronary Disease; Deoxyglucose; Echocardiography; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Myocardial Stunning; Sodium Pertechnetate Tc 99m; Thallium Radioisotopes; Tomography, Emission-Computed | 1995 |
Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
Topics: Blood Glucose; Carbon Radioisotopes; Coronary Disease; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Heart Failure; Heart Transplantation; Humans; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardium; Oxygen Consumption; Postoperative Complications; Prognosis; Tomography, Emission-Computed; Ventricular Function, Left | 1994 |
5 trial(s) available for fluorodeoxyglucose f18 and Heart Failure
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
18F-fluorodeoxyglucose use after cardiac transplant: A comparative study of suppression of physiological myocardial uptake.
Topics: Adult; Anticoagulants; Diet, Carbohydrate-Restricted; Diet, Diabetic; Fasting; Feasibility Studies; Female; Fluorodeoxyglucose F18; Heart Failure; Heart Transplantation; Heparin; Humans; Male; Middle Aged; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography | 2020 |
Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction.
Topics: Adult; Aged; Carbon Radioisotopes; Chronic Disease; Echocardiography; Exercise Tolerance; Female; Fluorodeoxyglucose F18; Glucagon-Like Peptide 1; Glucose; Heart Failure; Humans; Incretins; Male; Middle Aged; Myocardium; Oxygen Consumption; Positron Emission Tomography Computed Tomography; Quality of Life; Radiopharmaceuticals; Stroke Volume; Walk Test | 2016 |
Heart failure patients with prediabetes and newly diagnosed diabetes display abnormalities in myocardial metabolism.
Topics: Aged; Cicatrix; Coronary Circulation; Diabetes Complications; Diabetes Mellitus, Type 2; Disease Progression; Echocardiography; Female; Fluorodeoxyglucose F18; Glucose; Glucose Tolerance Test; Heart; Heart Failure; Humans; Liraglutide; Male; Metabolic Syndrome; Middle Aged; Myocardium; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Prediabetic State; Ventricular Dysfunction, Left | 2018 |
Effects of rosuvastatin on coronary flow reserve and metabolic mismatch in patients with heart failure (from the CORONA Study).
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Coronary Circulation; Dipyridamole; Exercise Test; Female; Fluorobenzenes; Fluorodeoxyglucose F18; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins; Male; Myocardium; Netherlands; Pilot Projects; Pyrimidines; Radiopharmaceuticals; Rosuvastatin Calcium; Sulfonamides; Tomography, Emission-Computed; Vasodilator Agents | 2010 |
56 other study(ies) available for fluorodeoxyglucose f18 and Heart Failure
Article | Year |
---|---|
Successful treatment of cardiac sarcoidosis based on clinical suspicion and advanced cardiac imaging: A case report.
Topics: Aged; Cardiomyopathies; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Myocarditis; Sarcoidosis; Stroke Volume; Ventricular Function, Left | 2022 |
Different displays of
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Heart Failure; Humans; Immune Checkpoint Inhibitors; Myocarditis; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Quinolines | 2023 |
Left ventricular assist device infection on
Topics: Fluorodeoxyglucose F18; Heart Failure; Heart-Assist Devices; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prosthesis-Related Infections | 2023 |
Value of 12-lead electrocardiogram to predict myocardial scar on FDG PET in heart failure patients.
Topics: Aged; Cicatrix; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Nitrogen Radioisotopes; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2021 |
Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction.
Topics: Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Stroke Volume | 2019 |
Contributory Role of Positron Emission Tomography in a Left Ventricular Assist Device Recipient at the Time of COVID-19 Pandemic.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Fluorodeoxyglucose F18; Heart Failure; Heart Ventricles; Heart-Assist Devices; Humans; Male; Middle Aged; Pandemics; Pneumonia, Viral; Positron-Emission Tomography; SARS-CoV-2 | 2020 |
Clinical and Imaging Response to Tumor Necrosis Factor Alpha Inhibitors in Treatment of Cardiac Sarcoidosis: A Multicenter Experience.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Stroke Volume; Tumor Necrosis Factor-alpha; Ventricular Function, Left | 2021 |
Comment on "Assessment of cerebral glucose metabolism in patients with heart failure by 18F-FDG PET/CT imaging".
Topics: Fluorodeoxyglucose F18; Glucose; Heart Failure; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Response to the comment on "Assessment of cerebral glucose metabolism in patients with heart failure by 18F-FDG PET/CT imaging".
Topics: Fluorodeoxyglucose F18; Glucose; Heart Failure; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
A Case of Rapidly Progressing Granulomatous Myocarditis: What Is the Diagnosis?
Topics: Atrioventricular Block; Biopsy; Cardiomyopathies; Diagnosis, Differential; Disease Progression; Echocardiography; Fluorodeoxyglucose F18; Giant Cells; Granuloma; Heart Block; Heart Failure; Heart Transplantation; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Myocardium; Natriuretic Peptide, Brain; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Stroke Volume; Troponin I | 2021 |
Mediastinum-type lung cancer on 68Ga-FAPI PET/CT with cardiac insufficiency as the first symptom.
Topics: Fluorodeoxyglucose F18; Heart Failure; Humans; Lung Neoplasms; Mediastinal Neoplasms; Mediastinum; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Rituximab; Sarcoidosis; Stroke Volume; Ventricular Function, Left | 2022 |
Diabetic db/db mice do not develop heart failure upon pressure overload: a longitudinal in vivo PET, MRI, and MRS study on cardiac metabolic, structural, and functional adaptations.
Topics: Adaptation, Physiological; Animals; Aorta; Arterial Pressure; Blood Glucose; Constriction; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Energy Metabolism; Fatty Acids; Fluorodeoxyglucose F18; Heart Failure; Magnetic Resonance Imaging; Male; Mice, Inbred C57BL; Myocardium; Phosphorylation; Positron-Emission Tomography; Predictive Value of Tests; Protein Kinase C; Proton Magnetic Resonance Spectroscopy; Radiopharmaceuticals; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2017 |
Assessment of attenuation correction for myocardial PET imaging using combined PET/MRI.
Topics: Aged; Aged, 80 and over; Algorithms; Artifacts; Female; Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Myocardial Perfusion Imaging; Myocardium; Normal Distribution; Positron-Emission Tomography; Retrospective Studies | 2019 |
Relationship of myocardial hibernation, scar, and angiographic collateral flow in ischemic cardiomyopathy with coronary chronic total occlusion.
Topics: Aged; Cardiomyopathies; Contrast Media; Coronary Angiography; Coronary Occlusion; Female; Fluorodeoxyglucose F18; Gadolinium; Heart; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardium; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2019 |
F-fluorodeoxyglucose-positive emission tomography/CT imaging for left ventricular assist device-associated infections in children.
Topics: Child; Child, Preschool; Diagnosis, Differential; Endocarditis, Bacterial; Female; Fluorodeoxyglucose F18; Heart Failure; Heart-Assist Devices; Humans; Prosthesis-Related Infections; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography | 2018 |
Diagnostic value of cardiac magnetic resonance and fluorodeoxyglucose-positron emission tomography for cardiac sarcoidosis with previous myocardial infarction: A case report.
Topics: Aged; Atrioventricular Block; Fluorodeoxyglucose F18; Heart Failure; Humans; Magnetic Resonance Angiography; Male; Multimodal Imaging; Myocardial Infarction; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2018 |
What Lies Within?: Imaging to Detect Ventricular Assist Device Infection.
Topics: Fluorodeoxyglucose F18; Heart Failure; Heart-Assist Devices; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2019 |
Radiation-induced myocardial damage indicated by focal defect on
Topics: 3-Iodobenzylguanidine; Echocardiography; Female; Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Iodine Radioisotopes; Middle Aged; Myocardium; Positron Emission Tomography Computed Tomography; Radiation Injuries; Tomography, Emission-Computed, Single-Photon | 2019 |
Imaging the Crevasse of Left Ventricular Assist Device Infection.
Topics: Fluorodeoxyglucose F18; Heart Failure; Heart Ventricles; Heart-Assist Devices; Humans; Positron Emission Tomography Computed Tomography | 2020 |
Assessment of the early stage of cardiac remodeling of spontaneously hypertensive heart failure rats using the quantitative 3-dimensional analysis provided by acipimox-enhanced FDG-PET.
Topics: Animals; Arterial Pressure; Cardiac Catheterization; Disease Models, Animal; Fibrosis; Fluorodeoxyglucose F18; Heart Failure; Heart Ventricles; Hypertension; Imaging, Three-Dimensional; Lipid Metabolism; Male; Positron-Emission Tomography; Predictive Value of Tests; Pyrazines; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stroke Volume; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2014 |
SPECT gated blood pool phase analysis of lateral wall motion for prediction of CRT response.
Topics: Aged; Area Under Curve; Cardiac Resynchronization Therapy; Cicatrix; Female; Fluorodeoxyglucose F18; Heart Failure; Heart Ventricles; Humans; Male; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Rubidium Radioisotopes; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2014 |
Gated F-18 FDG PET for assessment of left ventricular volumes and ejection fraction using QGS and 4D-MSPECT in patients with heart failure: a comparison with cardiac MRI.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Heart Failure; Heart Ventricles; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Reproducibility of Results; Stroke Volume; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2014 |
Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Atrioventricular Block; Biopsy; Cardiomyopathies; Defibrillators, Implantable; Disease-Free Survival; Electric Countershock; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Immunosuppressive Agents; Male; Middle Aged; Ontario; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Prospective Studies; Radiopharmaceuticals; Recurrence; Risk Factors; Sarcoidosis; Tachycardia, Ventricular; Time Factors; Tomography, X-Ray Computed; Young Adult | 2014 |
FDG PET/CT imaging for LVAD associated infections.
Topics: Aged; Early Diagnosis; Fluorodeoxyglucose F18; Heart Failure; Heart-Assist Devices; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prosthesis Design; Prosthesis-Related Infections; Radiopharmaceuticals; Tomography, X-Ray Computed; Ventricular Function, Left | 2014 |
Discrepant elevation of sIL-2R levels in sarcoidosis patients with renal insufficiency.
Topics: Biomarkers; Diabetic Nephropathies; Female; Fluorodeoxyglucose F18; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Heart Failure; Humans; Male; Middle Aged; Nephrotic Syndrome; Pilot Projects; Positron-Emission Tomography; Receptors, Interleukin-2; Regression Analysis; Renal Insufficiency; Retrospective Studies; Sarcoidosis | 2015 |
FDG-PET/CT for driveline infection in a patient with implantable left ventricular assist device.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Defibrillators, Implantable; Fluorodeoxyglucose F18; Heart Failure; Heart-Assist Devices; Humans; Male; Positron-Emission Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Contributory Role of Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis and Clinical Management of Infections in Patients Supported With a Continuous-Flow Left Ventricular Assist Device.
Topics: Anti-Bacterial Agents; Device Removal; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Failure; Heart-Assist Devices; Humans; Male; Middle Aged; Positron-Emission Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Malfunctioned cardiac resynchronization therapy attributed to acute exacerbation of cardiac sarcoidosis.
Topics: Adult; Cardiac Resynchronization Therapy; Cardiomyopathies; Disease Progression; Fluorodeoxyglucose F18; Glucocorticoids; Heart Failure; Humans; Male; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome | 2016 |
Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease.
Topics: Adult; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Myocardial Infarction; Myocarditis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis | 2017 |
Reverse Mismatch Pattern in Cardiac 18F-FDG Viability PET/CT Is Not Associated With Poor Outcome of Revascularization: A Retrospective Outcome Study of 91 Patients With Heart Failure.
Topics: Aged; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Myocardial Revascularization; Positron Emission Tomography Computed Tomography; Retrospective Studies; Treatment Outcome; Ventricular Function, Left | 2016 |
Relation of brain natriuretic peptide level to extent of left ventricular scarring in patients with chronic heart failure secondary to ischemic cardiomyopathy.
Topics: Aged; Chi-Square Distribution; Cicatrix; Echocardiography; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2009 |
18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial.
Topics: Canada; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Male; Middle Aged; Myocardial Revascularization; Patient Care Team; Positron-Emission Tomography; Professional Competence; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Survival Analysis; Tissue Survival; Ventricular Dysfunction, Left | 2010 |
Relation between right ventricular function and increased right ventricular [18F]fluorodeoxyglucose accumulation in patients with heart failure.
Topics: Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Glucose; Heart Failure; Heart Ventricles; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Ventricular Dysfunction, Right | 2011 |
Multimodality imaging in an unusual case of palpitations and right heart failure.
Topics: Aged; Carcinoid Heart Disease; Fatal Outcome; Female; Fluorodeoxyglucose F18; Heart Failure; Heart Neoplasms; Humans; Hydroxyindoleacetic Acid; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiography; Ultrasonography | 2011 |
Diagnosis and monitoring of cardiac sarcoidosis with delayed-enhanced MRI and 18F-FDG PET-CT.
Topics: Adult; Contrast Media; Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2012 |
Relationship between mechanical and metabolic dyssynchrony with left bundle branch block: evaluation by 18-fluorodeoxyglucose positron emission tomography in patients with non-ischemic heart failure.
Topics: Adult; Aged; Bundle-Branch Block; Case-Control Studies; Electrocardiography; Female; Fluorodeoxyglucose F18; Glucose; Heart Failure; Humans; Male; Middle Aged; Positron-Emission Tomography; Stroke Volume; Ventricular Dysfunction, Left | 2012 |
Metastatic human papillomavirus-positive nasopharyngeal carcinoma with an unusual pattern of aggressive hematogenous spread.
Topics: Alphapapillomavirus; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biomarkers, Tumor; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Diagnosis, Differential; Drug Administration Schedule; Fatal Outcome; Fluorodeoxyglucose F18; Fluorouracil; Heart Failure; Humans; Hypertension, Pulmonary; Hypoxia; Immunohistochemistry; Laryngoscopy; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Papillomavirus Infections; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Randomized Controlled Trials as Topic; Thrombophilia; Tomography, X-Ray Computed; Vascular Neoplasms | 2012 |
[F-18 fluorodeoxyglucose for diagnosis of myocardial viability: applications in clinical practice].
Topics: Fluorodeoxyglucose F18; Heart Failure; Heart Transplantation; Humans; Myocardial Infarction; Myocardial Revascularization; Myocardial Stunning; Prognosis; Sensitivity and Specificity; Tissue Survival; Tomography, Emission-Computed | 2002 |
Effect of biventricular pacing on myocardial glucose metabolism in patients with heart failure using fluoro-18-deoxyglucose positron emission tomography.
Topics: Aged; Cardiac Pacing, Artificial; Female; Fluorodeoxyglucose F18; Glucose; Heart; Heart Failure; Humans; Male; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Patterns of papillary muscle ischemia in myocardial PET.
Topics: Ammonia; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Muscular Diseases; Nitrogen Radioisotopes; Papillary Muscles; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Ga-67 citrate and F-18 FDG uptake in spironolactone-induced gynecomastia.
Topics: Artifacts; Citrates; Diuretics; Fluorodeoxyglucose F18; Gallium; Gynecomastia; Heart Failure; Humans; Male; Radionuclide Imaging; Radiopharmaceuticals; Spironolactone | 2005 |
Images in cardiovascular medicine. Fluorine-18-labeled deoxyglucose positron emission tomography in the diagnosis and management of aortitis with pulmonary artery involvement.
Topics: Aortitis; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Middle Aged; Positron-Emission Tomography; Prednisolone; Pulmonary Artery; Tomography, X-Ray Computed | 2005 |
Myocardial pre-synaptic sympathetic function correlates with glucose uptake in the failing human heart.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Fluorodeoxyglucose F18; Glucose; Heart; Heart Failure; Humans; Insulin Resistance; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Myocytes, Cardiac; Norepinephrine; Positron-Emission Tomography; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2007 |
Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Glucose; Circadian Rhythm; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Deoxyglucose; Energy Metabolism; Exercise Test; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Monitoring, Physiologic; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 1994 |
[Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
Topics: Aged; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Heart Aneurysm; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardium; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1994 |
Myocardial substrate utilization and left ventricular function in adriamycin cardiomyopathy.
Topics: Animals; Deoxyglucose; Doxorubicin; Fatty Acids; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Heart; Heart Failure; Iodine Radioisotopes; Iodobenzenes; Male; Myocardium; Rats; Rats, Wistar; Technetium Tc 99m Sestamibi; Ventricular Function, Left | 1993 |
Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy.
Topics: Aged; Ammonia; Coronary Artery Bypass; Coronary Disease; Deoxyglucose; Exercise Tolerance; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Male; Myocardium; Nitrogen Radioisotopes; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 1995 |
Clinical importance of viability assessment in chronic ischemic heart failure.
Topics: Chronic Disease; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 1996 |
[Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
Topics: Adult; Aged; Angina Pectoris; Blood Glucose; Coronary Artery Bypass; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardium; Postoperative Complications; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Function, Left | 1996 |
Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome.
Topics: Angina Pectoris; Case-Control Studies; Coronary Artery Bypass; Exercise Test; Exercise Tolerance; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Heart; Heart Failure; Humans; Male; Middle Aged; Myocardial Stunning; Predictive Value of Tests; Quality of Life; Radiopharmaceuticals; ROC Curve; Time Factors; Tomography, Emission-Computed; Treatment Outcome; Ventricular Dysfunction, Left | 1998 |
Ischemia and left ventricular dysfunction: a reciprocal relation?
Topics: Adult; Blood Flow Velocity; Coronary Disease; Dipyridamole; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Oxygen Consumption; Platelet Aggregation Inhibitors; Radiopharmaceuticals; Ventricular Dysfunction, Left | 1998 |
Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability.
Topics: Aged; Cardiotonic Agents; Coronary Artery Bypass; Dobutamine; Echocardiography; Exercise Test; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Failure; Humans; Male; Myocardial Ischemia; Prognosis; Prospective Studies; Quality of Life; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Ventricular Dysfunction, Left; Ventricular Function, Left | 1999 |
Hibernating myocardium: morphological correlates of inotropic stimulation and glucose uptake.
Topics: Adult; Aged; Biopsy; Cardiotonic Agents; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Dobutamine; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Stunning; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2000 |
[Efficacy of biventricular pacing on myocardial glucose metabolism in a patient with heart failure using 2-deoxy-2[18F]fluoro-d-glucose positron emission tomography: a case report].
Topics: Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Fluorodeoxyglucose F18; Glucose; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Abnormalities in myocardial contractility, metabolism and perfusion reserve in non-stenotic coronary segments in heart failure patients.
Topics: Aged; Case-Control Studies; Coronary Angiography; Coronary Circulation; Coronary Disease; Dipyridamole; Echocardiography, Stress; Energy Metabolism; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Myocardium; Perfusion; Tomography, Emission-Computed; Vasodilator Agents | 2002 |